3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Sarcoma
11
Osteosarcoma
4
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Central Nervous System Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Oligodendroglioma
2
Meningioma
2
Melanoma
2
Medulloblastoma
2
Lymphoma
2
Hemangiosarcoma
2
Gliosarcoma
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Brain Neoplasms
2
Bone Neoplasms
2
Astrocytoma
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Radiation Injuries
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Plexosarcoma
1
Pituitary Neoplasms
1
Interventions
Nivolumab
6
Imatinib Mesylate
4
Ipilimumab
3
Cetuximab
3
pembrolizumab
2
palbociclib
2
Specimen Handling
2
Radiotherapy
2
Radiosurgery
2
Protons
2
Proton Therapy
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Cyclophosphamide
2
tazemetostat
1
spartalizumab
1
relatlimab
1
nilotinib
1
camrelizumab
1
avelumab
1
atezolizumab
1
apatinib
1
Zoledronic Acid
1
X-Rays
1
Tiragolumab
1
Thiotepa
1
Surveys and Questionnaires
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Photochemotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chordoma
×
Surveys and Questionnaires
×
Sarcoma
×
Clear all
NCT06535997
2025-08-06
PRIMHADRON
Hospices Civils de Lyon
Completed
62 enrolled